These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1921573)

  • 1. Pharmacodynamic effects of transdermal bupranolol and timolol in vivo: comparison of microemulsions and matrix patches as vehicle.
    Kemken J; Ziegler A; Müller BW
    Methods Find Exp Clin Pharmacol; 1991 Jun; 13(5):361-5. PubMed ID: 1921573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of transdermally delivered bupranolol in rabbits: effect of chemical penetration enhancers.
    Babu RJ; Dhanasekaran M; Vaithiyalingam SR; Singh PN; Pandit JK
    Life Sci; 2008 Jan; 82(5-6):273-8. PubMed ID: 18096189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of supersaturation on the pharmacodynamic effect of bupranolol after dermal administration using microemulsions as vehicle.
    Kemken J; Ziegler A; Müller BW
    Pharm Res; 1992 Apr; 9(4):554-8. PubMed ID: 1495902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal timolol: beta blockade and plasma concentrations after application for 48 hours and 7 days.
    McCrea JB; Vlasses PH; Franz TJ; Zeoli L
    Pharmacotherapy; 1990; 10(4):289-93. PubMed ID: 2388875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems.
    Sintov AC; Botner S
    Int J Pharm; 2006 Mar; 311(1-2):55-62. PubMed ID: 16431047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The bioavailability of transdermal therapeutic system of timolol].
    Ji XF; Ping QN; Liu GJ; Yu ST
    Yao Xue Xue Bao; 1993; 28(8):609-13. PubMed ID: 8285070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timolol transport from microemulsions trapped in HEMA gels.
    Li CC; Abrahamson M; Kapoor Y; Chauhan A
    J Colloid Interface Sci; 2007 Nov; 315(1):297-306. PubMed ID: 17673246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microemulsions as topical drug delivery vehicles: in-vitro transdermal studies of a model hydrophilic drug.
    Osborne DW; Ward AJ; O'Neill KJ
    J Pharm Pharmacol; 1991 Jun; 43(6):450-4. PubMed ID: 1717675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of transdermal delivery of theophylline using microemulsion vehicle.
    Zhao X; Liu JP; Zhang X; Li Y
    Int J Pharm; 2006 Dec; 327(1-2):58-64. PubMed ID: 16926077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
    Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
    Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended release of lidocaine from linker-based lecithin microemulsions.
    Yuan JS; Acosta EJ
    Int J Pharm; 2009 Feb; 368(1-2):63-71. PubMed ID: 19010404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic analysis of systemic effect of topically applied timolol maleate ophthalmic gelling vehicle (Rysmon TG).
    Ohno Y; Iga T; Yamada Y; Nagahara M; Araie M; Takayanagi R
    Curr Eye Res; 2005 Apr; 30(4):319-28. PubMed ID: 16020262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of microemulsion systems for transdermal delivery of triptolide.
    Chen H; Chang X; Weng T; Zhao X; Gao Z; Yang Y; Xu H; Yang X
    J Control Release; 2004 Aug; 98(3):427-36. PubMed ID: 15312998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transdermal properties of timolol and factors affecting its permeability in vitro].
    Xu YZ; Xu HN
    Yao Xue Xue Bao; 1992; 27(6):467-71. PubMed ID: 1442076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oil phase composition on the skin permeation of felodipine from o/w microemulsions.
    Trotta M; Morel S; Gasco MR
    Pharmazie; 1997 Jan; 52(1):50-3. PubMed ID: 9035235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems.
    Babu RJ; Pandit JK
    Int J Pharm; 2005 Jan; 288(2):325-34. PubMed ID: 15620873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo and in vivo evaluation of transdermal formulation of trazodone hydrochloride.
    Das MK; Ghosal SK
    Acta Pol Pharm; 2008; 65(4):481-6. PubMed ID: 19051591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal delivery of hydrophobic and hydrophilic local anesthetics from o/w and w/o Brij 97-based microemulsions.
    Junyaprasert VB; Boonme P; Songkro S; Krauel K; Rades T
    J Pharm Pharm Sci; 2007; 10(3):288-98. PubMed ID: 17727792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.